Emerald Advisers’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-495,638
| Closed | -$18.5M | – | 304 |
|
|
2021
Q2 | $18.5M | Sell |
495,638
-29,294
| -6% | -$1.09M | 0.67% | 66 |
|
|
2021
Q1 | $13.4M | Sell |
524,932
-59,410
| -10% | -$1.52M | 0.48% | 88 |
|
|
2020
Q4 | $12.9M | Buy |
584,342
+66,858
| +13% | +$1.47M | 0.43% | 94 |
|
|
2020
Q3 | $9.31M | Sell |
517,484
-3,303
| -0.6% | -$59.4K | 0.38% | 88 |
|
|
2020
Q2 | $13.2M | Sell |
520,787
-147,337
| -22% | -$3.74M | 0.58% | 68 |
|
|
2020
Q1 | $12.3M | Sell |
668,124
-33,217
| -5% | -$610K | 0.71% | 54 |
|
|
2019
Q4 | $15.5M | Sell |
701,341
-172,268
| -20% | -$3.8M | 0.65% | 61 |
|
|
2019
Q3 | $12.5M | Sell |
873,609
-113,048
| -11% | -$1.62M | 0.59% | 72 |
|
|
2019
Q2 | $15.5M | Sell |
986,657
-9,703
| -1% | -$153K | 0.62% | 68 |
|
|
2019
Q1 | $14.6M | Sell |
996,360
-13,970
| -1% | -$205K | 0.59% | 64 |
|
|
2018
Q4 | $10.8M | Buy |
1,010,330
+37,708
| +4% | +$403K | 0.53% | 76 |
|
|
2018
Q3 | $14.8M | Buy |
972,622
+369,114
| +61% | +$5.63M | 0.55% | 84 |
|
|
2018
Q2 | $7.39M | Buy |
603,508
+574,804
| +2,003% | +$7.04M | 0.28% | 111 |
|
|
2018
Q1 | $274K | Sell |
28,704
-800
| -3% | -$7.64K | 0.01% | 231 |
|
|
2017
Q4 | $266K | Buy |
+29,504
| New | +$266K | 0.01% | 224 |
|
|
2015
Q2 | – | Sell |
-69,945
| Closed | -$1.55M | – | 387 |
|
|
2015
Q1 | $1.55M | Buy |
+69,945
| New | +$1.55M | 0.08% | 225 |
|